Discovering The EU’s Updates Regulatory Landscape & Updates

Join us for an afternoon of expert-led sessions on the latest EU (bio)pharmaceutical legislation, regulatory frameworks, and firsthand insights from the field. This half-day event is designed for regulatory professionals, market access experts, and decision-makers navigating the shifting landscape of EU pharma and clinical development.

During the welcome and the break Biotech Training Facility offers a tour of the state-of-the-art facility.

Event Agenda

12:00 – Lunch & Welcome
13:00 – Welcome and introduction of event and speakers
13:10 – New EU Pharma Legislation – Overview of the key aspects and status of implementation
14:00 – Orphan medicines and Paediatric Investigation Plans – Impact of the New EU Pharma Legislation
14:50 – Coffee Break
15:10 – New EU Health Technology Assessment Regulation – Overview of what’s new and status of the implementation
16:00 – Clinical Trial Regulation – status and first experiences after 3 years of effect
16:50 – Concluding remarks
17:00 – 17:30 Drinks, Snacks & Networking

Who should attend?

This seminar is relevant for Regulatory Affairs, Market Access & Pricing, Clinical Development, and/or Rare Disease & Paediatric Drug Development professionals working at biotech and pharma companies, or institutes.

Why join?

By attending, you’ll better understand how recent and upcoming EU regulatory changes may affect drug development and market access. The sessions will provide context to help you interpret these developments and consider their relevance to your work. It’s also an opportunity to connect with peers and exchange perspectives on shared regulatory and operational challenges.

Registration

Participation is free, but spaces are limited. Secure your spot today and stay informed on the regulatory changes shaping the EU pharmaceutical landscape!